Brookstone Capital Management’s Regulus Therapeutics RGLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
Sell
-110
Closed -$9K 426
2018
Q2
$9K Hold
110
﹤0.01% 367
2018
Q1
$9K Hold
110
﹤0.01% 344
2017
Q4
$14K Hold
110
﹤0.01% 307
2017
Q3
$16K Buy
+110
New +$16K ﹤0.01% 322